Treatment of Chronic Constipation using Elobixibat in a Real-World Setting: A Retrospective Cohort Study using an Electronic Medical Records Database in Japan

BACKGROUND: Chronic constipation is a common condition affecting people of all ages; therefore, the socioeconomic burden of chronic constipation is nonnegligible. Elobixibat (ELO), an ileal bail acid transport inhibitor, was launched in Japan in 2018. However, evidence of its use in diverse populati...

Descripción completa

Detalles Bibliográficos
Autores principales: Masaki, Hisanori, Shimamoto, Koji, Inokuchi, Shoichiro, Ishizaki, Sonoko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10685011/
https://www.ncbi.nlm.nih.gov/pubmed/38033932
http://dx.doi.org/10.1016/j.curtheres.2023.100724

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10685011/
https://www.ncbi.nlm.nih.gov/pubmed/38033932
http://dx.doi.org/10.1016/j.curtheres.2023.100724

Ejemplares similares